Dragonfly OCT
Device
Abbott Laboratories
Total Payments
$5.0M
Transactions
4,455
Doctors
852
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4.9M | 3,587 | 527 |
| 2020 | $56,699 | 297 | 177 |
| 2019 | $24,314 | 290 | 157 |
| 2018 | $21,659 | 281 | 168 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.0M | 1,735 | 80.4% |
| Consulting Fee | $624,366 | 295 | 12.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $128,281 | 136 | 2.6% |
| Food and Beverage | $92,135 | 2,109 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,556 | 11 | 1.0% |
| Travel and Lodging | $34,673 | 157 | 0.7% |
| Education | $32,297 | 6 | 0.6% |
| Grant | $13,409 | 5 | 0.3% |
| Charitable Contribution | $3,000 | 1 | 0.1% |
Payments by Type
Research
$4.0M
1,735 transactions
General
$976,718
2,720 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LIFE-BTK Randomized Controlled Trial | Abbott Laboratories | $908,623 | 0 |
| Validation of OCT-based FUnctional diagnoSIs of corONary stenosis | Abbott Laboratories | $876,581 | 0 |
| Optical Coherence Tomography (OCT) Guided Coronary Stent Implantation Compared to Angiography: a Multicenter Randomized Trial in PCI | Abbott Laboratories | $729,624 | 0 |
| Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow Percutaneous Left Ventricular Support Device (SHIELD II) | Abbott Laboratories | $546,588 | 0 |
| A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent48mm | Abbott Laboratories | $324,401 | 0 |
| XIENCE SHORT DAPT 28 US | Abbott Laboratories | $316,674 | 0 |
| FUSION | Abbott Laboratories | $195,377 | 0 |
| Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era (RECIPE) | Abbott Laboratories | $40,000 | 0 |
| Abbott Vascular Medical Device Registry | Abbott Laboratories | $31,683 | 0 |
| Perclose Multi-Access Duplex Ultra Sound | Abbott Laboratories | $28,415 | 0 |
| Fusion | Abbott Laboratories | $3,068 | 0 |
Top Doctors Receiving Payments for Dragonfly OCT — Page 7
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Pasadena, CA | $357.15 | 2 |
| , M.D | Cardiovascular Disease | Pasadena, CA | $357.13 | 2 |
| , D.O | Cardiovascular Disease | Corpus Christi, TX | $348.68 | 22 |
| , MD | Interventional Cardiology | Oxnard, CA | $348.45 | 2 |
| , M.D | Cardiovascular Disease | The Woodlands, TX | $337.76 | 2 |
| , M.D | Cardiovascular Disease | Tucson, AZ | $328.41 | 21 |
| , MD | Interventional Cardiology | Los Angeles, CA | $327.31 | 2 |
| , MD | Vascular & Interventional Radiology | Corpus Christi, TX | $310.98 | 14 |
| , MD | Interventional Cardiology | Houston, TX | $306.10 | 7 |
| , MD | Cardiovascular Disease | Staten Island, NY | $304.43 | 4 |
| , M.D, M.P.H | Internal Medicine | Dallas, TX | $304.07 | 7 |
| , MD | Cardiovascular Disease | Pasadena, CA | $302.62 | 9 |
| Lauren Richards | Interventional Cardiology | Milwaukee, WI | $302.27 | 2 |
| , M.D | Internal Medicine | Encino, CA | $295.32 | 3 |
| , MD, MS | Interventional Cardiology | Detroit, MI | $292.33 | 2 |
| , M.D | Internal Medicine | Washington, DC | $292.22 | 2 |
| , BMBS | Internal Medicine | Washington, DC | $292.22 | 2 |
| , DO | Internal Medicine | Willoughby, OH | $291.42 | 2 |
| , M.D | Cardiovascular Disease | Pasadena, CA | $290.21 | 12 |
| , D.O | Cardiovascular Disease | Austin, TX | $282.79 | 1 |
| John Moscona | Hospitalist | Austin, TX | $282.78 | 1 |
| , D.O | Internal Medicine | Chicago, IL | $281.31 | 2 |
| , M.D | Internal Medicine | Peoria, IL | $279.99 | 2 |
| , MD | Cardiovascular Disease | Corpus Christi, TX | $276.07 | 15 |
| , M.D | Internal Medicine | San Antonio, TX | $273.38 | 5 |
Ad
Manufacturing Companies
- Abbott Laboratories $5.0M
Product Information
- Type Device
- Total Payments $5.0M
- Total Doctors 852
- Transactions 4,455
About Dragonfly OCT
Dragonfly OCT is a device associated with $5.0M in payments to 852 healthcare providers, recorded across 4,455 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2021. In 2021, $4.9M was paid across 3,587 transactions to 527 doctors.
The most common payment nature for Dragonfly OCT is "Unspecified" ($4.0M, 80.4% of total).
Dragonfly OCT is associated with 11 research studies, including "LIFE-BTK Randomized Controlled Trial" ($908,623).